Bioavailability Studies and Assessment

Bioavailability is a subcategory of pharmacological absorption. Bioavailability is generally assessed by finding the area under the plasma concentration–time curve. The factors affecting bioavailability are Pharmaceutics factors, physicochemical properties of drug, Dosage form characteristics & Pharmaceutic Ingredients, Patient related factors like age, Routes of administration (Parenteral, Rectal, Oral, and Topical)  etc.

Conducting a BA study enables assessment of the impact of route of administration on BA and defines the absolute BA of the drug released from the drug product. BA for a given formulation provides an assessment of the relative fraction of the orally administered dose that is absorbed into the systemic circulation. If the reference standard is an IV dose, it is referred as Absolute Bioavailability. If the reference standard is any other dosage form than IV it is referred as Relative Bioavailability.

  • Nutrient Bioavailability
  • Absolute Bioavailability
  • Relative Bioavailability
  • Mineral Bioavailability- Micro and Macro
  • Vitamins Bioavailability
  • BA of Contaminants In Soils & Sediments

Related Conference of Bioavailability Studies and Assessment

November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Bioavailability Studies and Assessment Conference Speakers

Recommended Sessions

Related Journals

Are you interested in